Success Story: NIW Approved Without an RFE With Our Help for a Chinese Research Fellow
Client’s Testimonial:
“NAILG lawyers have been extremely professional and timely in putting together my EB-2 NIW petition. Thank you for your work and I would (and have indeed) highly recommend NAILG to friends and colleagues.”
On February 18th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Fellow in the Field of Biology (Approval Notice).
General Field: Biology
Position at the Time of Case Filing: Research Fellow
Country of Origin: China
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: February 18th, 2025
Processing Time: 9 months, 20 days
Case Summary:
With NAILG’s guidance, a biology researcher has earned EB-2 NIW (National Interest Waiver) approval for his impactful contributions to advancing cancer research through cutting-edge technologies. Holding a Ph.D. in Chemical and Systems Biology, the client has built a career dedicated to uncovering the molecular and systems-level mechanisms that govern cellular decision-making in cancer and immune cells.
His proposed endeavor focuses on utilizing single-cell multi-omic analysis and high-throughput microscopy to identify processes driving carcinogenesis and immune responses, with the ultimate goal of enabling more precise and effective treatments for cancer. This work directly addresses one of the most urgent public health challenges facing the United States while supporting national leadership in biotechnology and pharmaceutical innovation.
The importance of this research is further reflected in competitive funding support from the National Institute of General Medical Sciences (NIGMS). Such recognition underscores that the client’s work is not only scientifically sound but also aligned with critical national priorities in healthcare and disease prevention.
The client has also established a strong academic record. He has authored nine peer-reviewed journal articles (two first-authored) and one preprint, with his publications collectively cited 350 times according to Google Scholar. In addition, he has completed at least twelve peer reviews for leading scientific journals, demonstrating that his expertise is trusted by peers in the evaluation of cutting-edge research.
Experts in the field further emphasized the significance of his work in their recommendation letters. As one recommender explained: “As a renowned expert in the field of biology, [Client] has consistently demonstrated an unwavering commitment to enhancing the field’s comprehension of fundamental cellular processes.”
This NIW approval not only validates the national importance of the client’s research but also reflects the strength of the petition prepared by NAILG. With this success, the client is well-positioned to continue pioneering innovative biological research that advances cancer treatment and improves patient outcomes. NAILG is proud to have supported this case and looks forward to his continued contributions.